PharmD Degree Program

Study identifies lack of information about HER2 testing practices

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...

UCSF researchers join consortium to target cancer in new ways

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

Voigt Lab programs bacteria to perform increasingly complicated tasks

UCSF School of Pharmacy researchers and colleagues have successfully created a mathematical model that genetically programs bacteria and causes the bacteria to "trace" images projected onto them in a petri dish. The bacteria sense and display the area of the projection where light meets dark by...

Bero serves on IOM committee that reports on conflict of interest

UCSF School of Pharmacy researcher Lisa Bero, PhD, served with UCSF School of Medicine colleagues Bernard Lo, MD, and Deborah Grady,

Assemi named assistant dean of accreditation and quality improvement

Mitra Assemi, PharmD, UCSF School of Pharmacy associate professor of clinical pharmacy, has been named the School's assistant dean of accreditation and quality, effective September 1, 2009.

Kishi named associate dean of student and curricular affairs

Donald Kishi, PharmD, UCSF School of Pharmacy health sciences clinical professor of pharmacy, has been named the School's associate dean of student and curricular affairs by Dean Mary Anne Koda-Kimble, PharmD.

Two circuits found responsible for a cell’s ability to adapt

UCSF researchers have identified the two key circuits, compared to hundreds as previously thought, that control a cell's ability to adapt to changes in its environment. These circuits are key to a cell's ability to reset itself after responding to a stimulus.

New drug targeted for Kaposi’s sarcoma

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease.

Update from the Dean - Spring/Summer 2009

New chancellor: Desmond-Hellman; budget update: 4% to 10% salary cuts via furloughs, possibly to be renewed; risk of poison control system closure; new Department of Bioengineering and Therapeutic Sciences; faculty honors and awards: Burchard, Peck, Desai, Roy, Bero, MacDougall, Hessol, Phillips,...

Koda-Kimble shares her story

Mary Anne Koda-Kimble, dean of the UCSF School of Pharmacy, shares her life story, passion for clinical pharmacy, and leadership philosophy in this July 29, 2009 video.

Pages